EVO · Evotec SE
$1.96
-0.06 (-2.97%)
At close · Aug 14
Market Cap
$696.56M
Shares
355.39M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.96
Open$1.97
Day$1.94–1.98
52W close$1.91–4.15
Avg vol 30d73K
Short int48K · 0.0% float · 1.0d
Short vol31%
Last earningsAug 13, 2026
DataOct 2021–Aug 2026
Raw chart and full-history price indicators begin at the captured split on Oct 20, 2021; bars on opposite sides are not compared.
Up next
Next earnings call
Nov 13, 2026
Est · unconfirmed
· in 13 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Bearish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−34%
below
Price vs 50-day avg
−18%
below
RSI (14)
39
neutral
MACD trend
Positive
52-week position
2%
near low
Momentum
relative strength
1-month return
0%
trailing
6-month return
−42%
trailing
YTD return
−36%
this year
Relative strength
−56%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $3 — 200d above 50d
Institutional flow
Distributing
-26% holders QoQ · +7 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.01% of float · ▲ +68.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
34 holders — mid 3-yr range
Squeeze score
33
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
55%
annualized · 1-yr
Max drawdown
−54%
past year
ATR
4.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−34%
Bearish
Price vs 50-day avg
−18%
Bearish
RSI (14)
39
Neutral
MACD trend
Positive
Bullish
52-week position
2%
Bearish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $2 › 200d $3 — 200d above 50d
Institutional flow
Distributing
-26% holders QoQ · +7 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.01% of float · ▲ +68.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
34 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $2
Now $2 · 2%
Range high $4
vs 200-day avg -34%
vs 50-day avg -18%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
EVO
this stock
Evotec SE
|
$696.56M | -36.4% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$64.91B | — | — | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$56.30B | +13.1% | — | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$49.49B | +2.4% | — | — | 0.0% |
|
TEVA
Teva Pharmaceutical Industries Ltd
|
$42.85B | +17.8% | +4.3% | 60.3 | 2.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Performance
Raw-price comparisons begin at the captured split on Oct 20, 2021; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| EVO | -2.0% | +0.0% | -41.8% | +2.6% | -36.4% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | -2.4% | -4.5% | -55.6% | -1.3% | -50.2% |